/
/
/

Kimia Biosciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012Jun 2012
₹21 Cr₹27 Cr₹30 Cr₹34 Cr₹24 Cr₹38 Cr₹30 Cr₹28 Cr₹22 Cr₹30 Cr₹26 Cr₹24 Cr₹24 Cr₹23 Cr₹29 Cr₹40 Cr₹37 Cr₹30 Cr₹33 Cr₹31 Cr₹31 Cr₹36 Cr₹34 Cr₹38 Cr₹25 Cr₹21 Cr₹27 Cr₹32 Cr₹26 Cr₹19 Cr₹20 Cr₹33 Cr₹22 Cr₹18 Cr₹23 Cr₹21 Cr₹1 Cr₹98 L₹0₹49 L₹0₹1 L₹0₹14 L₹4 L₹6 L₹1 Cr₹9 L₹73 L₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹8 L₹1 Cr₹10 L-₹33 L₹85 L₹44 L₹42 L₹37 L₹8 L₹30 L₹58 L₹64 L₹13 L₹36 L₹26 L₹13 L₹45 L₹22 L₹22 L₹32 L₹17 L₹47 L₹55 L₹1 Cr₹37 L-₹8 L₹34 L₹16 L₹56 L₹2 Cr₹82 L₹60,000₹50,000₹50 L₹24 L₹21 L₹10 L₹28 L₹0₹4 L₹27 L₹6 L₹8 L₹40,000₹4 L₹66 L₹70,000₹70,000₹40,000₹2 L₹3 L₹0₹2 L₹2 L₹2 L₹0
₹21 Cr₹28 Cr₹30 Cr₹34 Cr₹24 Cr₹39 Cr₹31 Cr₹29 Cr₹22 Cr₹31 Cr₹27 Cr₹25 Cr₹24 Cr₹23 Cr₹29 Cr₹41 Cr₹37 Cr₹30 Cr₹33 Cr₹31 Cr₹31 Cr₹36 Cr₹35 Cr₹39 Cr₹25 Cr₹21 Cr₹28 Cr₹32 Cr₹26 Cr₹21 Cr₹21 Cr₹33 Cr₹22 Cr₹19 Cr₹23 Cr₹21 Cr₹1 Cr₹1 Cr₹0₹52 L₹27 L₹7 L₹8 L₹14 L₹9 L₹72 L₹1 Cr₹9 L₹73 L₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹19 Cr₹26 Cr₹24 Cr₹32 Cr₹22 Cr₹31 Cr₹26 Cr₹26 Cr₹20 Cr₹27 Cr₹28 Cr₹27 Cr₹27 Cr₹29 Cr₹33 Cr₹41 Cr₹35 Cr₹31 Cr₹34 Cr₹32 Cr₹30 Cr₹37 Cr₹33 Cr₹34 Cr₹23 Cr₹21 Cr₹27 Cr₹30 Cr₹25 Cr₹19 Cr₹19 Cr₹31 Cr₹21 Cr₹19 Cr₹22 Cr₹20 Cr₹2 Cr₹1 Cr₹33 L₹71 L₹28 L₹1 Cr₹72 L₹78 L₹1 Cr₹1 Cr₹1 Cr₹67 L₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr
₹2 Cr₹4 Cr₹7 Cr₹2 Cr₹3 Cr₹9 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr-₹47 L-₹1 Cr-₹2 Cr-₹5 Cr-₹3 Cr₹81 L₹3 Cr-₹14 L-₹13 L-₹4 L₹2 Cr₹39 L₹2 Cr₹5 Cr₹3 Cr₹58 L₹1 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹94 L-₹16 L₹2 Cr₹2 Cr-₹29 L-₹10 L-₹26 L-₹11 L₹7 L-₹97 L-₹56 L-₹56 L-₹1 Cr-₹16 L-₹14 L-₹54 L-₹80 L₹15 L₹16 L₹20 L₹64 L₹54 L₹38 L₹42 L
₹83 L₹75 L₹75 L₹27 L₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹83 L₹1 Cr₹90 L₹90 L₹78 L₹1 Cr₹77 L₹91 L₹70 L₹1 Cr₹57 L₹45 L₹42 L₹1 Cr₹15 L₹18 L₹27 L₹2 L₹26 L₹15 L₹8 L₹9 L₹2 L₹8 L₹8 L₹39 L₹14 L₹70,000₹2 L₹1 L₹60,000₹1 L₹1 L₹2 L₹2 L₹3 L₹4 L₹4 L₹6 L₹5 L
₹49 L₹2 Cr₹5 Cr₹95 L₹69 L₹6 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr-₹3 Cr-₹3 Cr-₹4 Cr-₹8 Cr-₹5 Cr-₹1 Cr₹1 Cr-₹2 Cr-₹2 Cr-₹2 Cr₹44 L-₹1 Cr₹1 Cr₹4 Cr₹2 Cr-₹95 L₹8 L₹2 Cr₹32 L-₹10 L₹2 Cr₹2 Cr₹40 L-₹52 L₹1 Cr₹1 Cr-₹48 L-₹31 L-₹35 L-₹26 L-₹9 L-₹1 Cr-₹77 L-₹65 L-₹1 Cr-₹30 L-₹28 L-₹59 L-₹93 L₹60,000₹1 L₹5 L₹49 L₹38 L₹21 L₹26 L
₹36 L₹37 L₹5 Cr₹1 Cr₹60 L₹2 Cr₹5 Cr₹2 Cr₹1 Cr₹2 Cr-₹2 Cr-₹2 Cr-₹3 Cr-₹6 Cr-₹3 Cr-₹83 L₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr₹32 L-₹91 L₹43 L₹4 Cr₹2 Cr-₹79 L₹8 L₹2 Cr₹32 L-₹5 L₹2 Cr₹2 Cr₹40 L-₹46 L₹1 Cr₹1 Cr-₹48 L-₹23 L-₹35 L-₹27 L-₹9 L-₹1 Cr-₹77 L-₹65 L-₹1 Cr-₹30 L-₹28 L-₹59 L-₹92 L₹60,000₹1 L₹5 L₹41 L₹38 L₹21 L₹26 L

Share Price Live Stats

Open (₹)30.60
Volume (₹)3,865.00
High (₹)30.75
Upper Circuit36.72
Low (₹)28.11
Lower Circuit24.48
Prev Close30.60
52W High (₹)43.28
Price28.95
52W Low (₹)23.20

Share Market Cap & Key Ratios Overview

M.Cap (₹)144.78 Cr
Div. Yield (%)0.00
PE Ratio20.15
Debt to Equity3.27
Price to Book20.18
Book Value2.11
EPS (TTM)1.52
Face Value1.00
ROE (%)186.70

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
KIMIABL-XNSE
LTP
1W Low
1W High
Market cap (₹)
1851.15+15.65 (0.85%)
1835.50
1890.40
4,47,476Cr
9634.5+267.5 (2.86%)
9305.95
9739.85
2,54,764Cr
4937.15+132.9 (2.77%)
4864.80
5010
1,89,423Cr
1176.05+23.05 (2.00%)
1152
1185
1,16,658Cr
1400+28.55 (2.08%)
1364
1418.70
1,11,484Cr
2037.55+82.3 (4.21%)
1964.50
2054.55
1,09,943Cr
2486.95+168.95 (7.29%)
2302.30
2503.20
1,01,712Cr
1198+26.9 (2.30%)
1186.20
1221.60
1,01,005Cr
1726.1-8.9 (-0.51%)
1690
1739.60
99,253Cr
2096.2-48.5 (-2.26%)
2084.50
2129.85
96,031Cr
28.95-0.44 (-1.50%)
28.11
31.01
145Cr

Key Highlights of Kimia Biosciences Ltd’s P&L

In 2025-03-31, Kimia Biosciences Ltd reported total revenue of ₹118.92Cr, compared with ₹104.88Cr in 2024-03-31, reflecting Kimia Biosciences Ltd turnover.

Depreciation was ₹3.38Cr and finance costs were ₹4.56Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹13.63Cr in 2025-03-31 as compared to ₹-₹7.18Cr in 2024-03-31.

Net Profit (PAT) was ₹9.61Cr in 2025-03-31 compared with ₹-₹5.31Cr in 2024-03-31.

Earnings per share (EPS) were ₹2.03 in 2025-03-31, compared with ₹-1.12 in 2024-03-31.